- Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria
-
Gonzalez M, McMullen A, Wallace MA, Crotty MP, Ritchie DJ, Burnham CA
- KMID: 2373640
- Ann Lab Med.
- 2017 Mar;37(2):174-176.
- doi: 10.3343/alm.2017.37.2.174
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients
-
Koh YR, Kim KH, Chang CL, Yi J
- KMID: 2373533
- Ann Lab Med.
- 2016 May;36(3):235-243.
- doi: 10.3343/alm.2016.36.3.235
BACKGROUND: We estimated the prevalence and clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA). The concordance between macromethod and glycopeptide resistance detection (GRD) E tests was determined. In addition, predictors... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa
-
Cho HH, Kwon KC, Kim S, Koo SH
- KMID: 1791936
- Ann Lab Med.
- 2014 Jul;34(4):286-292.
- doi: 10.3343/alm.2014.34.4.286
BACKGROUND: Pseudomonas aeruginosa is a clinically important pathogen that causes opportunistic infections and nosocomial outbreaks. Recently, the type III secretion system (TTSS) has been shown to play an important role... -
- CITED
-
- Close
- SHARE
-
- Close
- Macrolide Resistance of Mycoplasma pneumoniae and Its Detection Rate by Real-Time PCR in Primary and Tertiary Care Hospitals
-
Uh Y, Hong JH, Oh KJ, Cho HM, Park SD, Kim J, Yoon KJ
- KMID: 1711313
- Ann Lab Med.
- 2013 Nov;33(6):410-414.
- doi: 10.3343/alm.2013.33.6.410
BACKGROUND: This study aimed to evaluate the prevalence of Mycoplasma pneumoniae in primary and tertiary care hospitals and its macrolide resistance rate. METHODS: Nasopharyngeal swabs were collected from 195 pediatric patients... -
- CITED
-
- Close
- SHARE
-
- Close
